Search results
Results from the WOW.Com Content Network
It is used as eye drops or as a nasal spray. [2] The eye drops generally result in an improvement within half an hour. [2] Common side effects include headache, sore throat, eye discomfort, or changes in perception of taste. [3] [2] More significant side effects may include sleepiness. [2] It is unclear if use during pregnancy or breastfeeding ...
These side effects are usually mild and transient. Some individuals may experience throat irritation or coughing when using Fluticasone furoate inhalers. Rinsing the mouth and throat with water after inhalation can help reduce these symptoms. Headache is another common side effect reported with the use of Fluticasone furoate nasal spray or ...
A fentanyl nasal spray with a strength of 100 μg per use. The bioavailability of intranasal fentanyl is about 70–90% but with some imprecision due to clotted nostrils, pharyngeal swallow, and incorrect administration. For both emergency and palliative use, intranasal fentanyl is available in doses of 50, 100, 200, 400(PecFent) μg.
[3] [8] The nasal spray is used for prevention and treatment of allergic rhinitis. [2] Nasal drops are used in the treatment of nasal polyps. The nasal spray can also be used in the mouth for mouth ulcers. [11] Fluticasone propionate in a topical form can be used to treat skin conditions such as eczema, psoriasis, and rashes. [17] [18]
Xylometazoline, also spelled xylomethazoline, is a medication used to reduce symptoms of nasal congestion, allergic rhinitis, and sinusitis. [2] It is used directly in the nose as a spray or drops. [3] Side effects include trouble sleeping, irritation of the nose, nausea, nosebleed (3%), period pain (10%) and headache (3%).
Flu: A flu vaccine in nasal spray form was first approved by the FDA in 2003 and is available for people ages 2 to 49 who are not pregnant or immunocompromised. How nasal sprays might be used in ...
Since the effects of epinephrine last up to 30 minutes, experts note that most of these side effects will subside during that time. The nasal spray will officially hit the market in eight weeks.
Clinical trial number NCT02631551 for "Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-301)" at ClinicalTrials.gov Clinical trial number NCT02870205 for "Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301 ...